Craniocerebral Trauma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Craniocerebral Trauma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Report Format: PDF+Excel | Report ID: SR112024A9748
Buy Now

Market Overview:

The 7 major craniocerebral trauma markets are expected to exhibit a CAGR of 6.37% during 2024-2034.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2034
Historical Years
2018-2023
Market Growth Rate 2024-2034 6.37%


The craniocerebral trauma market has been comprehensively analyzed in IMARC's new report titled "Craniocerebral Trauma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Craniocerebral trauma, also known as traumatic brain injury (TBI), refers to an injury that occurs when an external force traumatically affects the brain, causing neurological damage. The severity of this ailment can range from mild to severe and can lead to various cognitive, physical, and psychological impairments. Some common indications of the disease include persistent headaches, dizziness, sensitivity to light and noise, nausea, vomiting, confusion, fatigue, drowsiness, slurred speech, ringing in the ears, memory problems, temporary loss of consciousness, etc. Individuals suffering from this illness may also experience coma, changes in behavior or personality, paralysis, and even death. The diagnosis of craniocerebral trauma involves a comprehensive assessment that includes a medical history, a physical examination, and various neurological tests. The healthcare provider will also perform numerous imaging techniques, like computed tomography (CT) scans and magnetic resonance imaging (MRI), to visualize the brain and detect tissue damage, contusions, or any other abnormalities. In some cases, the Glasgow Coma Scale (GCS) is further utilized to evaluate a patient's level of consciousness and neurological function. 

Craniocerebral Trauma Market

The rising incidences of head injuries due to accidents, falls, physical assaults, etc., that can cause damage to the brain tissues are primarily driving the craniocerebral trauma market. In addition to this, the escalating cases of intracranial hemorrhage, which can result in increased pressure within the skull, leading to neurological deficits, are also creating a positive outlook for the market. Moreover, the widespread adoption of several effective medications, such as non-steroidal anti-inflammatory drugs, stimulants, antidepressants, etc., to alleviate the symptoms of the disease and enhance the quality of life for patients is further bolstering the market growth. Apart from this, the inflating application of decompressive craniectomy procedures, since they involve removing a portion of the skull to allow the swollen brain tissue to expand, thereby reducing pressure inside the cranial cavity, is acting as another significant growth-inducing factor. Additionally, the emerging popularity of transcranial alternating current stimulation (tACS), which delivers alternating current to the brain to potentially synchronize neural activity and improve brain connectivity, is expected to drive the craniocerebral trauma market during the forecast period.

IMARC Group's new report provides an exhaustive analysis of the craniocerebral trauma market in the United States, EU4 (Germany, Spain, Italy, and France), United Kingdom, and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report, the United States has the largest patient pool for craniocerebral trauma and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario, unmet medical needs, etc., have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the craniocerebral trauma market in any manner.

Recent Developments:

  • In April 2024, US Army officials, in partnership with Abbott, revealed that the company’s i-STAT TBI (Traumatic Brain Injury) cartridge had received clearance from the United States Food and Drug Administration to be used with whole blood.


Key Highlights:

  • Every year, an estimated 5.48 million persons suffer from severe traumatic brain injury (TBI) (73 cases per 100,000).
  • According to the WHO, low- and middle-income countries (LMICs), where 85% of the population lives, account for over 90% of all injury-related deaths.
  • Every day, 153 persons in the United States die from injuries involving craniocerebral trauma.
  • Among all age categories, motor vehicle accidents were the third overall greatest cause of craniocerebral trauma-related ED visits, hospitalizations, and deaths (14%).
  • The rates were highest among people 75 and older.



Time Period of the Study

  • Base Year: 2023
  • Historical Period: 2018-2023
  • Market Forecast: 2024-2034


Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the craniocerebral trauma market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the craniocerebral trauma market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs


Competitive Landscape:

This report also provides a detailed analysis of the current craniocerebral trauma marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance


Key Questions Answered in this Report:

Market Insights

  • How has the craniocerebral trauma market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
  • What was the country-wise size of the craniocerebral trauma market across the seven major markets in 2023 and what will it look like in 2034?
  • What is the growth rate of the craniocerebral trauma market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?


Epidemiology Insights

  • What is the number of prevalent cases (2018-2034) of craniocerebral trauma across the seven major markets?
  • What is the number of prevalent cases (2018-2034) of craniocerebral trauma by age across the seven major markets?
  • What is the number of prevalent cases (2018-2034) of craniocerebral trauma by gender across the seven major markets?
  • How many patients are diagnosed (2018-2034) with craniocerebral trauma across the seven major markets?
  • What is the size of the craniocerebral trauma patient pool (2018-2023) across the seven major markets?
  • What would be the forecasted patient pool (2024-2034) across the seven major markets?
  • What are the key factors driving the epidemiological trend of craniocerebral trauma?
  • What will be the growth rate of patients across the seven major markets?
     

Craniocerebral Trauma: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for craniocerebral trauma drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the craniocerebral trauma market?
  • What are the key regulatory events related to the craniocerebral trauma market?
  • What is the structure of clinical trial landscape by status related to the craniocerebral trauma market?
  • What is the structure of clinical trial landscape by phase related to the craniocerebral trauma market?
  • What is the structure of clinical trial landscape by route of administration related to the craniocerebral trauma market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Craniocerebral Trauma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More